Genmab A (GMAB) Times Interest Earned (2019 - 2026)

Genmab A (GMAB) reported Times Interest Earned of -$1.2 for Q1 2026, up 71.28% on a YoY basis from -$0.7 in Q1 2025, and up 90.33% quarter-over-quarter from -$12.41 in Q3 2025.

Genmab A (GMAB) Times Interest Earned (2019 - 2026) Analysis & Trends

Genmab A has reported Times Interest Earned for 5 years, with the latest figure at -$1.2 in Q1 2026.

  • For the quarter ending Q1 2026, Times Interest Earned rose 71.28% year-over-year to -$1.2; the trailing twelve-month figure through Mar 2026 stood at -$4.27 (up 3.55% YoY), and the FY2025 full-year result was $3.96, up 18.53% from the prior year.
  • Times Interest Earned for Q1 2026 stood at -$1.2, up from -$12.41 in the prior quarter.
  • The five-year high for Times Interest Earned was -$1.2 in Q1 2026, with the low at -$12.41 in Q3 2025.
  • Historically, Times Interest Earned has averaged -$4.75 across 3 years, with a median of -$3.96 in 2025.
  • Annual changes were most pronounced in 2025 — Times Interest Earned tumbled 304.18% — and 2026, when it surged 71.28%.
  • Genmab A's Times Interest Earned stood at -$3.07 in 2024, then tumbled by 304.18% to -$12.41 in 2025, then soared by 90.33% to -$1.2 in 2026.
  • The last three Times Interest Earned figures came in at -$1.2 (Q1 2026), -$12.41 (Q3 2025), and -$3.96 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 3.58
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -258.33
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 11.50
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 547.67
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - 11.79
10 Genmab A 48.34 Bn 46.82 Bn 831.00 Mn -1.20

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.20
Sep 30, 2025 -12.41
Jun 30, 2025 -3.96
Mar 31, 2025 -4.18
Sep 30, 2024 -3.07
Jun 30, 2024 -5.13
Mar 31, 2024 -3.31
Sep 30, 2020 -1,191.67 Bn
Dec 31, 2019 -43.88